Related Experiment Videos
Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune
Abstract:
The possibility that macrophages mediate surveillance against the development of neoplasms has been reciving increasing support. The acquisition, by neoplastic cells, of the capacity to subvert macrophage function may be an important mechanism by which they escape destruction by the host and become established tumors. Indeed, animals implanted with syngeneic neoplasms developed depressed macrophage migratory ability in vivo and chemotactic responsiveness in virto. It therefore seemed plausible that neoplasms might be capable of producing inhibitors of macrophage function. The present report describes the identification of such a low molecular weight (6,000 to 10,000), heat-stable inhibitor of murine macrophage accumulation in vivo and chemotaxis in vitro. The inhibitor of macrophages was present in four different murine neoplasms, but not present in normal liver, spleen, or inflammatory exudate cells and did not affect PMN chemotaxis in vitro. When given with low numbers of neoplastic cells, the inhibitor increased both the frequency of tumor development and rate of tumor growth. By producing inhibitors of macrophage function, neoplasms may escape initial host surveillance mechanisms.
Insights
Tumors can produce a low molecular weight inhibitor that suppresses macrophage function, aiding tumor development. This discovery sheds light on how cancer cells evade the immune system.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Biology
Background:
- Macrophages play a crucial role in immune surveillance against neoplasms.
- Neoplastic cells may escape immune destruction by subverting macrophage functions.
- Impaired macrophage migration and chemotaxis are observed in tumor-bearing animals.
Purpose of the Study:
- To identify potential inhibitors of macrophage function produced by neoplasms.
- To investigate the role of such inhibitors in tumor development and growth.
Main Methods:
- Characterization of a low molecular weight, heat-stable inhibitor from murine neoplasms.
- Assay of inhibitor's effect on macrophage accumulation in vivo and chemotaxis in vitro.
- Evaluation of the inhibitor's impact on tumor development and growth when co-administered with neoplastic cells.
Main Results:
- A low molecular weight (6-10 kDa), heat-stable inhibitor of macrophage function was identified in four murine neoplasms.
- The inhibitor suppressed macrophage accumulation in vivo and chemotaxis in vitro.
- The inhibitor was absent in normal tissues and did not affect polymorphonuclear neutrophil (PMN) chemotaxis.
- Co-administration of the inhibitor with neoplastic cells increased tumor incidence and growth rate.
Conclusions:
- Neoplasms can produce inhibitors that impair macrophage-mediated immune surveillance.
- These tumor-derived inhibitors may represent a key mechanism for neoplastic cells to escape host defenses.
- Targeting these inhibitors could offer novel therapeutic strategies for cancer treatment.